Evidence map›Paper›PMID 36830747›Full record

ReviewBiomolecules2023

Mitochondrial Neurodegeneration: Lessons from

Michele Brischigliaro, Erika Fernandez-Vizarra, Carlo Viscomi

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Mitochondrial complex I deficiency-associated diseases and models.Cellular and molecular life sciences : CMLS · 2026
    Review
  3. bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michele BrischigliaroDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy.ORCID 0000-0003-1520-1342
Erika Fernandez-VizarraDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy.ORCID 0000-0002-2469-142X
Carlo ViscomiDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy.ORCID 0000-0001-6050-0566
University of Padua · IT

Funding

Associazione Luigi Comini Onlus MitofightDepartment of Biomedical Sciences-UNIPD FERN_FAR22_01Department of Biomedical Sciences-UNIPD SID2022- VISC_BIRD2222_01French Muscular Dystrophy Association 23706Telethon Foundation GGP20013Telethon Foundation GJC21014
6 · The paper itself

Abstract

The fruit fly-i.e.,

Indexed as

Drosophila melanogasterMitochondrial DiseasesAnimalsDrosophilaMitochondriaOxidative PhosphorylationDrosophila melanogastermitochondrial diseaseneurodegenerationOXPHOS

Identifiers

PMID36830747
PMCPMC9953451
OpenAlexW4321251644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.